Saturday , 2 March 2024
Home Health U.S. FDA to review Perrigo’s birth control pill for OTC use in November
Health

U.S. FDA to review Perrigo’s birth control pill for OTC use in November

Sept 12 (Reuters) - Perrigo Co Plc (PRGO.N) said on Monday that the U.S. Food and Drug Administration had scheduled a meeting of external experts on Nov. 18 to review the application of its daily birth control pill for over-the-counter (OTC) use.

 

Continue reading your article with a FrontPage News Subscription

Already a Subscriber? Sign In  

OR
VIEW SUBSCRIPTION OPTIONS
Support independent journalism by subscribing